CompletedPhase 2NCT00376987

Zinc Supplements in Lowering Cadmium Levels in Smokers

RATIONALE: Zinc supplements may lower cadmium levels in smokers and may help prevent DNA damage. PURPOSE: This clinical trial is studying how well zinc supplements work in lowering cadmium levels in smokers.

Checked against the public recordLast updated May 30, 2017 · Source: ClinicalTrials.gov

StatusCompleted
PhasePhase 2
U.S. locations1
SponsorWake Forest University Health Sciences
01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Phase 2
Sponsor
Wake Forest University Health Sciences
Interventions being studied
Dietary Supplement: zinc oxide
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

DISEASE CHARACTERISTICS: * Currently smoking ≥ 1 pack (20 cigarettes) per day * Baseline cadmium level ≥ 0.5 μg/L PATIENT CHARACTERISTICS: * Negative pregnancy test * Fertile patients must use effective contraception * No known gastrointestinal upset due to zinc vitamins or lozenges PRIOR CONCURRENT THERAPY: * At least 2 weeks since prior and no other concurrent vitamins and zinc supplements

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Wake Forest University Comprehensive Cancer CenterWinston-Salem, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 30, 2017. Always confirm current availability with the study team.

View original record ↗